Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lytone Enterprise, Inc. (1293:TWSE), powered by AI.
Lytone Enterprise, Inc. is currently trading at $28.15. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Lytone Enterprise, Inc. on Alpha Lenz.
View Lytone Enterprise, Inc.'s valuation metrics on Alpha Lenz.
“Lytone Enterprise, Inc.'s ROE is 14.8%. Explore profitability and growth together.”
Ask for details →Lytone Enterprise, Inc. is a Taiwan-based company specializing in the research, development, and distribution of biotechnology products for the food, agriculture, and animal husbandry sectors. Founded in 1994, its core business revolves around designing functional food ingredients, health foods, agricultural biotechnologies, and animal health supplements—including probiotics and feed additives. Lytone Enterprise offers science-based and patented solutions, such as post-harvest technologies to improve produce shelf life, functional fertilizers, and a range of products targeting health areas including bones, joints, gastrointestinal health, and metabolic syndrome. The company’s reach is international, serving clients not only in Taiwan but also across China, Europe, the Americas, Japan, Korea, Southeast Asia, Oceania, and East Africa. Its commitment to health, sustainability, and innovation is reflected in its numerous industry awards and extensive patent portfolio, making it a key contributor to the advancement of food technology and agricultural biotechnology worldwide.
“Lytone Enterprise, Inc.'s ROE is 14.8%. Explore profitability and growth together.”
Ask for details →Lytone Enterprise, Inc. (ticker: 1293) is a company listed on TWSE in the Consumer Defensive sector (Farm Products).
The current price is 28.15 with a P/E ratio of -x and P/B of -x.
ROE is 14.81% and operating margin is 6.22%. Annual revenue is $763M.